Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the future.

If you are a healthcare professional and have a question about an Exelixis product, please contact Exelixis Medical Information at [email protected] or call 1-855-292-3935 (EXEL).

* Sairopa B.V. (Sairopa) and Exelixis have an exclusive clinical development and option agreement providing Exelixis the right to acquire ADU-1805. ADC = antibody-drug conjugate; …

Exelixis extends its impact through strategic collaborations across drug discovery, development and commercialization, building on our long history of productive partnerships to move our …

Qualified and interested candidates should apply to current openings on our Exelixis Careers website or on LinkedIn, Glassdoor and Indeed. Exelixis accepts no responsibility for any costs …

One of Exelixis’ greatest strengths is its culture of focused execution. We’re committed to moving quickly while turning over every stone to bring new standards of care to physicians and …

As we seek to improve the treatment of patients with cancer, Exelixis is addressing a broad array of targets selected based on rigorous scientific and clinical evidence with the goal of …

As we scale our business, pipeline and infrastructure to meet the challenges posed by cancer on a global scale, patients remain at the center of everything we do. At Exelixis, the ultimate …

Dec 4, 2023 · – STELLAR-305 is Exelixis’ first pivotal study in squamous cell carcinoma of the head and neck – – Trial will evaluate the potential of inhibition of VEGF, MET and AXL, which …

Developing new medicines is an iterative process. After testing potential compounds in labs and selecting drug candidates to study further, Exelixis conducts research and clinical trials to …